Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Apricus expands Vitaros agreement with Ferring, terminates agreement with Sandoz

July 27, 2016

Resverlogix begins dosing in phase I study of apabetalone in severe renal impairment

July 22, 2016

FDA accepts Revive's IND for a phase II trial of bucillamine for cystinuria

July 7, 2016

Pfizer introduces AMPK activators

June 22, 2016

FDA approves Rayaldee for secondary hyperparathyroidism in CKD

June 21, 2016

Boehringer Ingelheim discloses aldosterone synthase inhibitors

June 20, 2016

Astellas Pharma and Kotobuki Pharmaceutical patent leucyl-cystinyl aminopeptidase antagonists

June 17, 2016

Eli Lilly and Company develops PKC inhibitors

June 3, 2016

FDA issues complete response letter for sodium zirconium cyclosilicate for hyperkalemia

May 27, 2016

Linaclotide shows preclinical potential for bladder hyperactivity

May 25, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 26, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Dual-targeting, rapamycin-enhanced CAR T for multiple myeloma
BioWorld Science
Umoja Biopharma Inc. performed preclinical studies to evaluate the antitumor activity of UB-VV500, an off-the-shell lentiviral vector CAR T-cell product. It is...